JUNE 20259EUROPEblockchain into existing regulatory frameworks for clinical trials and data privacy, laws still pose a significant challenge.Next, the lack of interoperability and standardisation among different blockchain platforms and electronic health record systems complicates data sharing and integration efforts within the clinical trial ecosystem. Scalability issues inherent in blockchain technology, such as network congestion and transaction processing speed, may hinder its widespread adoption for managing large-scale clinical trials with extensive data volumes.Cost and infrastructure: The initial setup costs associated with implementing blockchain infrastructure, including hardware, software, and especially personnel training, can be prohibitive for smaller research and biotech organisations with limited resources. Therefore, it is very likely that early adopters of blockchain in medical research will be big pharma and large national and supra-national big data consortia. User adoption and education about the benefits and intricacies of blockchain technology and overcoming resistance to change among clinicians, researchers, and participants are crucial for successful adoption. While blockchain offers enhanced security through its cryptographic features, ensuring data privacy and protection against unauthorised must remain in focus, particularly regarding sensitive patient information, which is paramount to the integrity of data. This requires that so-called smart contracts, which automate and enforce the terms of agreements on the blockchain, must be rigorously tested and audited before deployment as well as in use to ensure their reliability and accuracy in executing protocols of complex clinical trials and real-world evidence-generating platforms. This further expands to address any ethical concerns related to data ownership and consent management.Navigating these challenges will require collaborative efforts among researchers, industry stakeholders, regulatory bodies, and technology providers to develop tailored solutions and frameworks that address the unique requirements of clinical and medical evidence generation while harnessing the transformative potential of blockchain technology.Landscape of Real-World Evidence Evolving in the FutureThe landscape of real-world evidence is definitely expected to evolve significantly in the future, with several key trends and implications for the healthcare industry. RWE is becoming more widely adopted and integrated into healthcare decision-making processes across various stakeholders, including healthcare providers, regulators, payers, and policymakers. RWE, combined with advancement in diagnostics, is also facilitating the long-awaited transition towards personalised and precision medicine. This personalised approach to healthcare will eventually lead to more targeted interventions, improved patient outcomes, and optimised resource allocation.Advice to Healthcare Professionals and Researchers Seeking to Leverage Real-World Evidence in Their Work (i) Clearly define the research objectives and outcomes desired from leveraging real-world evidence. Establishing specific goals will guide the selection of appropriate data sources and methodologies. (ii) Prioritise only high-data quality sources to ensure the reliability, accuracy, and completeness of real-world data and implement robust data validation and cleaning processes to mitigate biases and errors. (iii) Leverage advanced analytical techniques such as machine learning, natural language processing, and predictive modelling to extract meaningful insights from complex real-world datasets and uncover hidden patterns. These are prerequisites for translating real-world evidence findings into actionable insights and recommendations for healthcare decision-makers, policymakers, and stakeholders to inform clinical practice, healthcare policy, and resource allocation. For healthcare professionals in routine practice on a primary and secondary level, it will be essential to embrace a culture of continuous learning and understanding of research methodologies and data collection processes to maximise learnings from real-world experiences and to effectively harness the power of real-world evidence to drive evidence-based decision-making, improve patient outcomes, and advance healthcare delivery and innovation.
< Page 8 | Page 10 >